EFFICACY OF RECOMBINANT THROMBOMODULIN AND ANTITHROMBIN COMBINATION THERAPY IN SEPSIS-INDUCED DIC

被引：0
|
作者：
Takahashi, Hiroyuki
Kuriyama, Keiichi
Yoshikawa, Kazuhide
Ueki, Yuzuru
Takahashi, Masateru
Isotani, Eiji
机构：
来源：
CRITICAL CARE MEDICINE | 2015年 / 43卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1019
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced DIC
    K Yamakawa
    H Ogura
    S Fujimi
    M Morikawa
    Y Ogawa
    Y Umemura
    Y Inoue
    H Tanaka
    T Hamasaki
    T Shimazu
    Critical Care, 18 (Suppl 1):
  • [2] Efficacy of the combined therapy with recombinant human soluble thrombomodulin and antithrombin in septic DIC patients
    Kitamura, T.
    Ishikura, H.
    Murai, A.
    Tanaka, J.
    Nishida, T.
    Ohta, D.
    Kamitani, T.
    Umemura, T.
    Sugimura, T.
    Matsuo, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 426 - 426
  • [3] Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
    Wada, Hideo
    Kawasugi, Kazuo
    Honda, Goichi
    Kawano, Noriaki
    Uchiyama, Toshimasa
    Madoiwa, Seiji
    Takezako, Naoki
    Suzuki, Kei
    Seki, Yoshinobu
    Ikezoe, Takayuki
    Iba, Toshiaki
    Okamoto, Kohji
    TH OPEN, 2023, 07 (01) : e65 - e75
  • [4] The efficacy and safety of antithrombin and recombinant human thrombomodulin combination therapy in patients with severe sepsis and disseminated intravascular coagulation
    Yasuda, Norihisa
    Goto, Koji
    Ohchi, Yoshifumi
    Abe, Takakuni
    Koga, Hironori
    Kitano, Takaaki
    JOURNAL OF CRITICAL CARE, 2016, 36 : 29 - 34
  • [5] Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
    Iba, Toshiaki
    Nakarai, Etsuro
    Takayama, Toshio
    Nakajima, Kenji
    Sasaoka, Tetsumasa
    Ohno, Yoichi
    CRITICAL CARE, 2009, 13 (06):
  • [6] Combination effect of antithrombin and recombinant human soluble thrombomodulin in a lipopolysaccharide induced rat sepsis model
    Toshiaki Iba
    Etsuro Nakarai
    Toshio Takayama
    Kenji Nakajima
    Tetsumasa Sasaoka
    Yoichi Ohno
    Critical Care, 13
  • [7] EFFECTS OF COMBINATION THERAPY OF RECOMBINANT HUMAN SOLUBLE THROMBOMODULIN AND ANTITHROMBIN ON DISSEMINATED INTRAVASCULAR COAGULATION WITH SEVERE SEPSIS
    Ikeda, K.
    INTENSIVE CARE MEDICINE, 2012, 38 : S295 - S295
  • [8] Factors Determining the Efficacy of Recombinant Human Thrombomodulin in the Treatment of Sepsis-Induced Disseminated Intravascular Coagulation
    Kotake, Kazumasa
    Hongo, Takashi
    Tahira, Akihiro
    Niimi, Nana
    Haisa, Ikue
    Kawakami, Yasuhiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2021, 44 (05) : 605 - 610
  • [9] EVALUATION OF ENDOTHELIAL MICROPARTICLES IN SEPSIS INDUCED DIC TREATED BY RECOMBINANT THROMBOMODULIN
    Takahashi, Hiroki
    Matsumoto, Hisatake
    Ogura, Hiroshi
    Yamakawa, Kazuma
    Koh, Taichin
    Matsumoto, Naoya
    Shimazu, Takeshi
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [10] EFFECTS OF RECOMBINANT HUMAN THROMBOMODULIN ON SEPSIS-INDUCED DISSEMINATED INTRAVASCULAR COAGULATION
    Uemura, Tatsuki
    Hiruma, Hiromitsu
    Hagiwara, Akiyoshi
    Makinouchi, Ryuichiro
    Matsuda, Wataru
    Kimura, Akio
    CRITICAL CARE MEDICINE, 2015, 43 (12)
12345